Trials / Completed
CompletedNCT00576108
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Kalypsys, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of 2 weeks of topical KD7040 versus placebo in the treatment of postherpetic neuralgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KD7040 Topical Gel | KD7040 topical gel |
| DRUG | Placebo gel | Placebo gel |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2007-12-18
- Last updated
- 2008-07-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00576108. Inclusion in this directory is not an endorsement.